PT87424A - Expression of foreign genes in drosophila cells - Google Patents

Expression of foreign genes in drosophila cells

Info

Publication number
PT87424A
PT87424A PT87424A PT8742488A PT87424A PT 87424 A PT87424 A PT 87424A PT 87424 A PT87424 A PT 87424A PT 8742488 A PT8742488 A PT 8742488A PT 87424 A PT87424 A PT 87424A
Authority
PT
Portugal
Prior art keywords
foreign genes
expression
drosophila cells
drosophila
cells
Prior art date
Application number
PT87424A
Other languages
English (en)
Other versions
PT87424B (pt
Inventor
Hanne Ranch Johansen
Martin Rosenberg
Der Straten-Ponthoz Ariane Van
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of PT87424A publication Critical patent/PT87424A/pt
Publication of PT87424B publication Critical patent/PT87424B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT87424A 1987-05-08 1988-05-05 Metodo de producao de tpa e de expressao de genes estranhos em celulas de drosophila PT87424B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4773687A 1987-05-08 1987-05-08

Publications (2)

Publication Number Publication Date
PT87424A true PT87424A (pt) 1989-05-31
PT87424B PT87424B (pt) 1992-09-30

Family

ID=21950656

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87424A PT87424B (pt) 1987-05-08 1988-05-05 Metodo de producao de tpa e de expressao de genes estranhos em celulas de drosophila

Country Status (13)

Country Link
EP (1) EP0290261B1 (pt)
JP (1) JP2706260B2 (pt)
AT (1) ATE90969T1 (pt)
AU (1) AU618952B2 (pt)
CA (1) CA1341345C (pt)
CY (1) CY1929A (pt)
DE (1) DE3881953T2 (pt)
DK (1) DK175595B1 (pt)
ES (1) ES2058274T3 (pt)
HK (1) HK1006852A1 (pt)
IE (1) IE63005B1 (pt)
PT (1) PT87424B (pt)
ZA (1) ZA883213B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01108995A (ja) * 1987-10-23 1989-04-26 Hoechst Japan Kk 培養動物細胞による蛋白質の産生を向上させるための遺伝子増幅方法
CA2003794C (en) * 1988-12-01 2000-02-08 Hanne R. Johansen Expression of hiv proteins in drosophila cells
AU634512B2 (en) * 1988-12-21 1993-02-25 Smithkline Biologicals Expression of the plasmodium circumsporozoite protein in insect cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
IE56716B1 (en) * 1983-01-19 1991-11-20 Genentech Inc Method for producing human tpa and expression vectors therefor
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
JP2515299B2 (ja) * 1986-06-03 1996-07-10 三井東圧化学株式会社 ヒ−トシヨツクたんぱく質遺伝子ｈｓｐ８３を含む発現ベクタ−及びこれを用いる誘導的発現

Also Published As

Publication number Publication date
EP0290261B1 (en) 1993-06-23
EP0290261A1 (en) 1988-11-09
DE3881953D1 (de) 1993-07-29
JP2706260B2 (ja) 1998-01-28
PT87424B (pt) 1992-09-30
JPS63304982A (ja) 1988-12-13
DK243388D0 (da) 1988-05-04
AU618952B2 (en) 1992-01-16
AU1551088A (en) 1988-11-10
CA1341345C (en) 2002-03-05
IE63005B1 (en) 1995-03-22
CY1929A (en) 1997-05-16
ATE90969T1 (de) 1993-07-15
ES2058274T3 (es) 1994-11-01
DE3881953T2 (de) 1993-09-30
ZA883213B (en) 1989-03-29
DK175595B1 (da) 2004-12-13
DK243388A (da) 1988-11-09
IE881373L (en) 1988-11-08
HK1006852A1 (en) 1999-03-19

Similar Documents

Publication Publication Date Title
FI862756A0 (fi) Fibroektiner.
ES2061512T3 (es) Polipeptidos de nor-estatina y nor-cicloestatina.
DE69020107D1 (de) Herstellung von peroxid enthaltenden perfluorpolyäthern.
ATE116857T1 (de) Oligodesoxynukleotide als inhibitoren der replikation von retroviren und der expression von onkogenen.
ATE333893T1 (de) Gentherapie für gaucher-krankheit
NO853851L (no) Human livmorsvevplasminogenaktivator fremstilt ved rekombi nant-dna.
DE69433168D1 (de) In vitro vermehrung von stammzellen
DE3854223D1 (de) Erzeugung und Anzeige von Rechnergraphiken.
ES2043607T3 (es) Agentes fibrinoliticos modificados.
DK0506791T3 (da) Enzymholdigt præparat og detergent indeholdende et sådant præparat
FI943122A0 (fi) Menetelmiä trombiinin tuottamiseksi
PT87424A (pt) Expression of foreign genes in drosophila cells
DE3876221D1 (de) Absorption von schwefelwasserstoff.
DK491988D0 (da) Modificerede plasminogen-aktivatorer
DK112290A (da) Vaevsplasminogenaktivator-variant
ZA872530B (en) Large scale production of plasminogen activator from normal human colon cells
DE3888505D1 (de) Herstellung von Zimtsäureestern.
KR890701732A (ko) 개량형 조직 플라스미노겐 활성화 인자
DE69020783D1 (de) Stabilisierung von Wasserstoffsuperoxyd in Tests.
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.
MN422A8 (en) Purification of discoloured blood of cattle from hydrogen peroxide involving catalase enzymes
AU100024S (en) Musical instrument

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920306

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080505